Heparin Sodium Injection, Solution
Product Images NDC 51662-1687

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Heparin Sodium (NDC 51662-1687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1687 Structure1)

Chemical structure diagram showing five numbered molecular components related to Heparin Sodium. The structures include ringed sugar moieties with various functional groups such as hydroxyl, sulfate, acetyl, and amino groups, illustrating the complex polysaccharide nature of Heparin Sodium.*

FDA Label Image

Table (51662 1687 Table 1 2)

A data table titled 'Recommended Adult Full-Dose Heparin Regimens for Therapeutic Anticoagulant Effect,' detailing administration methods, dosing frequency, and recommended doses for intermittent intravenous and continuous intravenous infusion of heparin. It includes notes and dosage bases for a 150 lb adult patient. Additional pediatric use dosing guidelines and monitoring instructions for heparin therapy are listed below the table.*

FDA Label Image

Label (51662 1687 1 Rfid1)

A close-up view of a label on HEPARIN SODIUM injection solution packaging. The label includes a barcode and text with numeric codes and expiry information. It states distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275, and advises seeing the manufacturer's insert. The label designation RX ONLY is visible next to the barcode.*

FDA Label Image

Label (51662 1687 2 Pouch1)

Label showing Heparin Sodium injection, solution in 0.45% sodium chloride, with a concentration of 25,000 USP units per 250 mL (100 USP units/mL). The NDC is 51662-1687-2, with lot number 789210 and expiration date 2030-09-19. Distributed by HF Acquisition Co., LLC., Mukilteo, WA 98275. The label includes storage instructions and regulatory information.*

FDA Label Image

Label (51662 1687 3 Case1)

Label for Heparin Sodium Injection, Solution in 0.45% Sodium Chloride with a concentration of 25,000 USP units per 250 mL (100 USP units/mL). The label includes the NDC 51662-1687-3 and lot number 789210 with an expiration date of 2030-09-19. Distributed by HF Acquisition Co., LLC in Mukilteo, WA 98275.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.